Solventum Corporation (SOLV) Stock Analysis & Winston Score

Solventum Corporation makes medical and healthcare products used in hospitals, clinics, and dental offices. Its main product lines include wound care supplies, surgical tools, dental materials, and health information software. The company was spun off from 3M in 2024, inheriting a large portfolio of established healthcare brands that 3M had built over decades. Solventum earns money by selling its products and software to healthcare providers around the world, with a mix of one-time product sales and recurring software subscriptions. It operates globally, with significant revenue from North America and Europe, and generates roughly $8 billion in annual revenue. Its main competitive advantage is its deep relationships with hospitals and clinicians, along with a broad product catalog that is costly for customers to replace — however, the company carries a heavy debt load from the spinoff, which limits its financial flexibility and is a key risk investors watch closely.